Phenominer Database Results (25 results)

 

How to display a graph
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Value Units SEM SD Method Method Site Method Duration Post Insult Type Post Insult Time Value Post Insult Time Unit Method Notes Clinical Measurement Notes Record ID Study ID
ACI/SegHsd pituitary gland wet weight diethylstilbestrol (5 mg) (for 84 days) and surgical implantation Strecker TE, et al., Genetics 2005 Jan 31;. pituitary gland mass male 147 days 14 0.08 g 0.0 0.01 post excision weight measurement 0.0 subcutaneous implant 84 days diethylstilbestrol 69101 1122
BN/SsNHsd percentage of study population developing pituitary tumors that replace the entire gland during a period of time diethylstilbestrol (5 mg) (for 70 days) and surgical implantation (for 70 days) Pandey J, et al., Carcinogenesis 2004 May 27;. pituitary gland integrity trait not specified 91 days 6 0.0 % ex vivo light microscopy 0.0 surgery implant 70 days xco:0000295 69910 1240
BN/SsNHsd percentage of study population developing pituitary tumors that invade the glandular capsule during a period of time diethylstilbestrol (5 mg) (for 70 days) and surgical implantation (for 70 days) Pandey J, et al., Carcinogenesis 2004 May 27;. pituitary gland integrity trait not specified 91 days 6 0.0 % ex vivo light microscopy 0.0 surgery implant 70 days xco:0000295 69911 1240
F344.BN-(D5Rat1-D5Mit5)/Dlw percentage of study population developing pituitary gland hyperplastic lesions during a period of time diethylstilbestrol (5 mg) (for 70 days) and surgical implantation (for 70 days) Pandey J, et al., Carcinogenesis 2004 May 27;. pituitary gland integrity trait not specified 91 days 6 0.0 % ex vivo light microscopy 0.0 surgery implant 70 days xco:0000295 69916 1240
ACI/SegHsd binary logarithm of pituitary gland wet weight surgical implantation then 17 beta-estradiol (27.5 mg) (between 193 and 199 days) Shull JD, et al., Mamm Genome. 2007 Sep 18;. pituitary gland mass female 252 days-266 days 9 7.15 null 0.12 0.36 post excision weight measurement pituitary gland 0 0 logarithm of pituitary wet weight 65770 331
BN/SsNHsd thymus wet weight diethylstilbestrol (5 mg) (for 84 days) and surgical implantation Gould KA, et al., Mamm Genome. 2006 May;17(5):451-64. thymus mass male 147 days 15 66.0 mg 4.39 17.0 post excision weight measurement 0.0 subcutaneous implant 84 days diethylstilbestrol 69095 1121
F344.BN-(D3Mgh13-D3Mgh7)/Dlw lactotroph count to total pituicyte count ratio in prolactinoma diethylstilbestrol (5 mg) (for 70 days) and surgical implantation (for 70 days) Pandey J and Wendell DL, Mamm Genome. 2006 Jan;17(1):49-57. Epub 2006 Jan 13. pituitary gland integrity trait female 91 days 0 93.4 % ex vivo light microscopy with immunohistochemistry 0.0 subcutaneous implant 70 days 97079 1838
COP/CrCrl pituitary gland wet weight diethylstilbestrol (5 mg) (for 84 days) and surgical implantation Strecker TE, et al., Genetics 2005 Jan 31;. pituitary gland mass male 147 days 28 0.04 g 0.0 0.01 post excision weight measurement 0.0 subcutaneous implant 84 days diethylstilbestrol 69107 1122
BN/SsNHsd binary logarithm of pituitary gland wet weight surgical implantation then 17 beta-estradiol (27.5 mg) (between 193 and 199 days) Shull JD, et al., Mamm Genome. 2007 Sep 18;. pituitary gland mass female 252 days-266 days 10 3.79 null 0.07 0.21 post excision weight measurement pituitary gland 0 0 logarithm of pituitary wet weight 65768 331
BN/SsNHsd percentage of study population developing pituitary gland hyperplastic lesions during a period of time diethylstilbestrol (5 mg) (for 70 days) and surgical implantation (for 70 days) Pandey J, et al., Carcinogenesis 2004 May 27;. pituitary gland integrity trait not specified 91 days 6 100.0 % ex vivo light microscopy 0.0 surgery implant 70 days xco:0000295 69908 1240
F344.BN-(D5Rat1-D5Mit5)/Dlw percentage of study population developing pituitary tumors that replace a portion of the gland during a period of time diethylstilbestrol (5 mg) (for 70 days) and surgical implantation (for 70 days) Pandey J, et al., Carcinogenesis 2004 May 27;. pituitary gland integrity trait not specified 91 days 6 67.0 % ex vivo light microscopy 0.0 surgery implant 70 days xco:0000295 69917 1240
F344.BN-(D5Rat1-D5Mit5)/Dlw percentage of study population developing pituitary tumors that invade the glandular capsule during a period of time diethylstilbestrol (5 mg) (for 70 days) and surgical implantation (for 70 days) Pandey J, et al., Carcinogenesis 2004 May 27;. pituitary gland integrity trait not specified 91 days 6 67.0 % ex vivo light microscopy 0.0 surgery implant 70 days xco:0000295 69919 1240
F344/NHsd lactotroph count to total pituicyte count ratio in prolactinoma diethylstilbestrol (5 mg) (for 70 days) and surgical implantation (for 70 days) Pandey J and Wendell DL, Mamm Genome. 2006 Jan;17(1):49-57. Epub 2006 Jan 13. pituitary gland integrity trait female 91 days 0 99.1 % ex vivo light microscopy with immunohistochemistry 0.0 subcutaneous implant 70 days 97077 1838
BN/SsNHsd percentage of study population developing pituitary tumors that replace a portion of the gland during a period of time diethylstilbestrol (5 mg) (for 70 days) and surgical implantation (for 70 days) Pandey J, et al., Carcinogenesis 2004 May 27;. pituitary gland integrity trait not specified 91 days 6 0.0 % ex vivo light microscopy 0.0 surgery implant 70 days xco:0000295 69909 1240
F344/NHsd percentage of study population developing pituitary gland hyperplastic lesions during a period of time diethylstilbestrol (5 mg) (for 70 days) and surgical implantation (for 70 days) Pandey J, et al., Carcinogenesis 2004 May 27;. pituitary gland integrity trait not specified 91 days 6 0.0 % ex vivo light microscopy 0.0 surgery implant 70 days xco:0000295 69912 1240
F344/NHsd percentage of study population developing pituitary tumors that replace a portion of the gland during a period of time diethylstilbestrol (5 mg) (for 70 days) and surgical implantation (for 70 days) Pandey J, et al., Carcinogenesis 2004 May 27;. pituitary gland integrity trait not specified 91 days 6 50.0 % ex vivo light microscopy 0.0 surgery implant 70 days xco:0000295 69913 1240
F344/NHsd percentage of study population developing pituitary tumors that replace the entire gland during a period of time diethylstilbestrol (5 mg) (for 70 days) and surgical implantation (for 70 days) Pandey J, et al., Carcinogenesis 2004 May 27;. pituitary gland integrity trait not specified 91 days 6 50.0 % ex vivo light microscopy 0.0 surgery implant 70 days xco:0000295 69914 1240
F344/NHsd percentage of study population developing pituitary tumors that invade the glandular capsule during a period of time diethylstilbestrol (5 mg) (for 70 days) and surgical implantation (for 70 days) Pandey J, et al., Carcinogenesis 2004 May 27;. pituitary gland integrity trait not specified 91 days 6 50.0 % ex vivo light microscopy 0.0 surgery implant 70 days xco:0000295 69915 1240
F344.BN-(D5Rat1-D5Mit5)/Dlw percentage of study population developing pituitary tumors that replace the entire gland during a period of time diethylstilbestrol (5 mg) (for 70 days) and surgical implantation (for 70 days) Pandey J, et al., Carcinogenesis 2004 May 27;. pituitary gland integrity trait not specified 91 days 6 33.0 % ex vivo light microscopy 0.0 surgery implant 70 days xco:0000295 69918 1240
F344.BN-(D5Rat1-D5Mit5)/Dlw lactotroph count to total pituicyte count ratio in prolactinoma diethylstilbestrol (5 mg) (for 70 days) and surgical implantation (for 70 days) Pandey J, et al., Carcinogenesis 2004 May 27;. pituitary gland integrity trait not specified 91 days 6 86.0 % 9.0 22.05 ex vivo light microscopy 0.0 surgery implant 70 days xco:0000295 lactotroph to total pituicyte ratio 69920 1240
COP/CrCrl pituitary gland wet weight diethylstilbestrol (5 mg) (for 84 days) and surgical implantation Strecker TE, et al., Genetics 2005 Jan 31;. pituitary gland mass male 147 days 14 0.03 g 0.0 0.01 post excision weight measurement 0.0 subcutaneous implant 84 days diethylstilbestrol 69103 1122
ACI/SegHsd pituitary gland wet weight diethylstilbestrol (5 mg) (for 84 days) and surgical implantation Strecker TE, et al., Genetics 2005 Jan 31;. pituitary gland mass male 147 days 28 0.07 g 0.0 0.01 post excision weight measurement 0.0 subcutaneous implant 84 days diethylstilbestrol 69105 1122
ACI/SegHsd thymus wet weight diethylstilbestrol (5 mg) (for 84 days) and surgical implantation Gould KA, et al., Mamm Genome. 2006 May;17(5):451-64. thymus mass male 147 days 13 166.0 mg 6.1 22.0 post excision weight measurement 0.0 subcutaneous implant 84 days diethylstilbestrol 69099 1121
ACI/SegHsd pituitary gland wet weight surgical implantation then 17 beta-estradiol (27.5 mg) (between 193 and 199 days) Shull JD, et al., Mamm Genome. 2007 Sep 18;. pituitary gland mass female 252 days-266 days 9 0.15 g 0.01 0.04 post excision weight measurement pituitary gland 0 0 13093 331
BN/SsNHsd pituitary gland wet weight surgical implantation then 17 beta-estradiol (27.5 mg) (between 193 and 199 days) Shull JD, et al., Mamm Genome. 2007 Sep 18;. pituitary gland mass female 252 days-266 days 10 0.01 g 0.0 0.0 post excision weight measurement pituitary gland 0.0 0 13102 331